EGFR and colonic neoplasm: Another study demonstrated that right-sided colon cancers had higher rates of MSI, more frequent aberrant activation of the EGFR/MAPK pathway including higher BRAF mutation rates and an increased mutational burden compared to left-sided CRCs [36].